Naproxen Sodium
- Product NDC
- 33261-085
- 11-digit product format
- 332610085
- Labeler code
- 33261
- Product ID
- 33261-085_f67ff8f9-fff1-4cd4-abc6-819b577837dc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA078432
- Marketing category
- ANDA
- Marketing start
- 2007-04-26
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 550 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 33261-085 | I | Inactivated by FDA | 2026-10-05 | ||
| excluded package | package | 33261-085 | 33261-085-00 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-02 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-14 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-20 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-21 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-30 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-60 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-84 | I | Inactivated by FDA | 2026-10-05 | |
| excluded package | package | 33261-085 | 33261-085-90 | I | Inactivated by FDA | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-00 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-30 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-60 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-21 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-84 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-14 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-90 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-20 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 33261-085-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-00 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-30 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-60 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-21 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-84 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-14 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-90 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-20 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33261-085-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-00 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-30 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-60 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-21 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-84 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-14 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-90 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-20 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33261-085-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-00 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-30 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-60 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-21 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-84 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-14 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-90 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-20 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33261-085-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-00 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-30 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-60 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-84 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-14 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-90 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-20 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33261-085-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-00 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-30 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-60 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-21 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-84 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-14 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-90 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-20 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33261-085-02 | cdf11ea48f46… | ba0047e9e063… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078432-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | ||
| A078432-002 | NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | 2007-04-25 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | 2007-04-25 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A078432-001 | NAPROXEN SODIUM | EQ 250MG BASE | TABLET / ORAL | AB | 2007-04-25 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A078432-002 | NAPROXEN SODIUM | EQ 500MG BASE | TABLET / ORAL | AB | 2007-04-25 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078432-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078432-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078432-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078432-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078432-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078432-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078432-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078432-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078432-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078432-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078432-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078432-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078432-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078432-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A078432-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A078432-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078432-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078432-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A078432-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A078432-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A078432-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A078432-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A078432-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A078432-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A078432-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A078432-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A078432-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A078432-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078432-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078432-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A078432-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A078432-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A078432-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A078432-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A078432-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A078432-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A078432-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A078432-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A078432-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A078432-002 | AB | 1 | b00525d2431f… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33261-085-00 | Naproxen Sodium | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 1 | |
| 33261-085-02 | Naproxen Sodium | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | 1 | |
| 33261-085-14 | Naproxen Sodium | 14 in 1 BOTTLE, PLASTIC | TABLET | 14 | 1 | |
| 33261-085-20 | Naproxen Sodium | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 1 | |
| 33261-085-21 | Naproxen Sodium | 21 in 1 BOTTLE, PLASTIC | TABLET | 21 | 1 | |
| 33261-085-30 | Naproxen Sodium | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 1 | |
| 33261-085-60 | Naproxen Sodium | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 1 | |
| 33261-085-84 | Naproxen Sodium | 84 in 1 BOTTLE, PLASTIC | TABLET | 84 | 1 | |
| 33261-085-90 | Naproxen Sodium | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33261-085-00 | EA - Each | 33261-085 | 5a093d2c-8b45-408b-86dd-339a0c6ce274 | 1 | 2015-10-02 |
| 33261-085-02 | EA - Each | 33261-085 | 5b64841a-4fcb-423c-9fe2-d4f3eb4ba2e0 | 1 | 2014-02-04 |
| 33261-085-14 | EA - Each | 33261-085 | 600894a0-cbdd-4620-a7f7-e7a0f5f929cc | 1 | 2014-02-04 |
| 33261-085-20 | EA - Each | 33261-085 | 8cc6287c-f602-4631-9434-5451e57afcc8 | 1 | 2014-02-04 |
| 33261-085-21 | EA - Each | 33261-085 | 10544f3d-9f68-47b2-ac3c-e9ca614c983f | 1 | 2014-02-04 |
| 33261-085-30 | EA - Each | 33261-085 | 73b66fad-c50b-4e85-a38c-0802510bbb07 | 1 | 2015-10-02 |
| 33261-085-60 | EA - Each | 33261-085 | 40298a87-ed12-4718-bf17-f43e663bbdac | 1 | 2014-02-04 |
| 33261-085-84 | EA - Each | 33261-085 | 2148411a-16e7-4c72-8082-6711c0987646 | 1 | 2015-10-02 |
| 33261-085-90 | EA - Each | 33261-085 | 9c54c69d-298e-4db9-9653-82ac890d04ec | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAPROXEN SODIUM | ACTIVE INGREDIENT | 9TN87S3A3C | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | NAPROXEN SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 849398 | naproxen sodium 275 MG Oral Tablet | PSN | 30cc16cd-720d-4baa-8941-bfdc28b62b04 | 1 |
| 849431 | naproxen sodium 550 MG Oral Tablet | PSN | 30cc16cd-720d-4baa-8941-bfdc28b62b04 | 1 |
| 849398 | naproxen sodium 275 MG Oral Tablet | SCD | 30cc16cd-720d-4baa-8941-bfdc28b62b04 | 1 |
| 849431 | naproxen sodium 550 MG Oral Tablet | SCD | 30cc16cd-720d-4baa-8941-bfdc28b62b04 | 1 |
| 849398 | naproxen sodium 275 MG (as naproxen 250 MG) Oral Tablet | SY | 30cc16cd-720d-4baa-8941-bfdc28b62b04 | 1 |
| 849431 | naproxen sodium 550 MG (as naproxen 500 MG) Oral Tablet | SY | 30cc16cd-720d-4baa-8941-bfdc28b62b04 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 33261-085-00 | 33261008500 | 100 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-02 | 33261008502 | 120 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-14 | 33261008514 | 14 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-20 | 33261008520 | 20 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-21 | 33261008521 | 21 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-30 | 33261008530 | 30 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-60 | 33261008560 | 60 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-84 | 33261008584 | 84 in 1 BOTTLE, PLASTIC | Historical |
| 33261-085-90 | 33261008590 | 90 in 1 BOTTLE, PLASTIC | Historical |